Stem Cell Cancer And Regenerative Medicine Research Inc is located in Boynton Beach, FL. The organization was established in 2007. According to its NTEE Classification (H90) the organization is classified as: Medical Disciplines Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Stem Cell Cancer And Regenerative Medicine Research Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Stem Cell Cancer And Regenerative Medicine Research Inc generated $240.8k in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 53.3% each year . All expenses for the organization totaled $275.8k during the year ending 12/2021. While expenses have increased by 7.4% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
SEE SCHEDULE O FOR DESCRIPTION THE ORGANIZATION IS TO BE OPERATED FOR SCIENTIFIC AND EDUCATIONAL PURPOSES TO CONDUCT RESEARCH TO UNCOVER THE MOLECULAR BASIS OF CANCER AND DEGENERATIVE DISEASES WITH THE EMPHASIS ON CANCER INCLUDING MULTIPLE MYELOMA AND OTHER CHRONIC DISEASES INCLUDING FRAILTY..
Describe the Organization's Program Activity:
Part 3 - Line 4a
IN MAY 2008 THE ORGANIZATION STARTED A COLLABORATION WITH SCIENTISTS AT WAKE FOREST UNIVERSITY WHO HAVE DEVELOPED A PROTOCOL FOR USING GRANULOCYTES FOR TREATING SOLID TUMORS. THE PROTOCOL WAS MODIFIED FOR IMPLEMENTATION AND INVESTIGATIONAL NEW DRUG APPROVAL WAS OBTAINED IN OCTOBER 2008 FOR A PHASE I/II CLINICAL TRIAL FOR 29 PATIENTS. WESTERN INSTITUTIONAL REVIEW BOARD APPROVAL WAS OBTAINED IN NOVEMEBER 2008. THROUGH 2021, 17 PATIENTS HAVE BEEN TREATED AND 244 DONORS HAVE BEEN EVALUATED.
YOUNG BLOOD CLINICAL STUDY UNDER FOOD AND DRUG ADMINISTRATION APPROVAL EVALUATING THE SAFETY AND EFFICACY OF FRESH FROZEN PLASMA (GMFFP) FROM YOUNG HEALTHY DONORS AGES 18 TO 35, WHO HAVE GRANULOCYTE - COLONY STIMULATING FACTOR (G-CSF) TO AMELIORATE FRAILTY AND ENHANCE THE IMMUNE RISK PROFILE IN OLDER INDIVIUALS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Scott Santarella Director | Trustee | 20 | $66,664 |
Dipnarine Maharaj MD President, Director | OfficerTrustee | 6 | $0 |
Jacqueline Gouvea MD Secretary, Treasurer, Dire | OfficerTrustee | 4 | $0 |
Terrell W Witcher Director | Trustee | 2 | $0 |
Daniel Mangru Director | Trustee | 1 | $0 |
Susan Maharaj Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $240,472 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $240,472 |
Total Program Service Revenue | $0 |
Investment income | $369 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $240,841 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $66,664 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $5,699 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $9,200 |
Travel | $2,633 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $1,129 |
All other expenses | $3,550 |
Total functional expenses | $275,836 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $641,364 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $15,105 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $656,469 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $3,016 |
Total liabilities | $3,016 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $653,453 |
Total liabilities and net assets/fund balances | $656,469 |
Over the last fiscal year, we have identified 2 grants that Stem Cell Cancer And Regenerative Medicine Research Inc has recieved totaling $100,020.
Awarding Organization | Amount |
---|---|
Collis Foundation Providence, RI PURPOSE: GENERAL OPERATING SUPPORT | $100,000 |
Amazonsmile Foundation Seattle, WA PURPOSE: GENERAL SUPPORT | $20 |
Organization Name | Assets | Revenue |
---|---|---|
Foundation For Orthopaedic Research And Education Inc Tampa, FL | $1,560,496 | $3,465,860 |
Tampa Va Research And Education Foundation Inc Temple Terrace, FL | $4,353,686 | $3,415,527 |
Bay Pines Foundation Inc Bay Pines, FL | $1,266,331 | $1,296,485 |
Pediatric Heart Transplant Society Foundation Birmingham, AL | $63,523 | $386,033 |
Vaccine And Gene Therapy Institute Of Florida Corp Port St Lucie, FL | $217,466 | $19 |
South Carolina Orthopaedic Association Temple Terrace, FL | $68,707 | $322,769 |
Stem Cell Cancer And Regenerative Medicine Research Inc Boynton Beach, FL | $656,469 | $240,841 |
Joseph M Still Research Foundation Inc Augusta, GA | $285,106 | $464,408 |
American Society For Metabolic And Bariatric Surgery Foundation Inc Newberry, FL | $1,171,870 | $349,808 |
Bashan Institute Of Science Inc Auburn, AL | $1,081,907 | $303,203 |
Corrona Research Foundation Delray Beach, FL | $198,653 | $50,000 |
Association Of Standardized Patient Educators Inc Altamonte Springs, FL | $352,946 | $213,286 |